Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II

Nature

Volumn 435, Issue 7040, 2005, Pages 347-353

  Choi, Min Hee ^a   Lee, In Kyung ^a   Kim, Gyung Whan ^b   Kim, Bang Ul ^a   Han, Ying Hao ^c   Yu, Dae Yeul ^c   Park, Hye Sun ^a   Kim, Kyung Yong ^d   Lee, Jong Seo ^d   Choi, Chulhee ^a,f   Bae, Yun Soo ^a   Lee, Byung In ^b   Rhee, Sue Goo ^e   Kang, Sang Won ^a  

^a Ewha Womans University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d KSBC Bldg   (South Korea)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; ENZYME KINETICS; ENZYMES; GROWTH KINETICS; MUSCLE; PROTEINS;

GROWTH FACTOR; INTRACELLULAR PRODUCTION; PLATELET-DERIVED GROWTH FACTOR (PDGF); VASCULAR REMODELING;

CARDIOVASCULAR SYSTEM;

EPIDERMAL GROWTH FACTOR; HYDROGEN PEROXIDE; MITOGENIC AGENT; PEROXIDASE; PEROXIREDOXIN; PHOSPHOLIPASE C GAMMA; PLATELET DERIVED GROWTH FACTOR; PHOSPHOTYROSINE; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

MEDICINE;

ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL; CARDIOVASCULAR DISEASE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RESTENOSIS; TISSUE REGENERATION; VASCULAR SMOOTH MUSCLE; ANGIOGENESIS; ANIMAL; AORTA; CAROTID ARTERY; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROTEIN BINDING; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ANIMALIA; MAMMALIA; MURINAE;

ANIMALS; AORTA; CAROTID ARTERIES; CELLS, CULTURED; CORONARY RESTENOSIS; ENZYME ACTIVATION; HUMANS; MICE; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; PEROXIDASES; PHOSPHORYLATION; PHOSPHOTYROSINE; PLATELET-DERIVED GROWTH FACTOR; PROTEIN BINDING; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 19644394554     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03587     Document Type: Article

References (23)

1. Heldin, C. H. & Westermark, B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79, 1283-1316 (1999).
2. 2 for platelet-derived growth factor signal transduction. Science 270, 296-299 (1995).
3. 2 production requires the activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 275, 10527-10531 (2000).
4. Kang, S. W. et al. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J. Biol. Chem. 273, 6297-6302 (1998).
5. Rhee, S. G., Kang, S. W., Chang, T. S., Jeong, W. & Kim, K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52, 35-41 (2001).
6. Wood, Z. A., Schroder, E., Robin Harris, J. & Poole, L. B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28, 32-40 (2003).
7. Chae, H. Z., Kim, H. J., Kang, S. W. & Rhee, S. G. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res. Clin. Pract. 45, 101-112 (1999).
8. Kim, H. K. et al. PDGF stimulation of inositol phospholipid hydrolysis requires PLC-γ1 phosphorylation on tyrosine residues 783 and 1254. Cell 65, 435-441 (1991).
9. Baxter, R. M., Secrist, J. P., Vaillancourt, R. R. & Kazlauskas, A. Full activation of the platelet-derived growth factor β-receptor kinase involves multiple events. J. Biol. Chem. 273, 17050-17055 (1998).
10. Rhee, S. G. & Bae, Y. S. Regulation of phosphoinositide-specific phospholipase C isozymes. J. Biol. Chem. 272, 15045-15048 (1997).
11. Sekiya, F., Poulin, B., Kim, Y. J. & Rhee, S. G. Mechanism of tyrosine phosphorylation and activation of phospholipase C-γ1. Tyrosine 783 phosphorylation is not sufficient for lipase activation. J. Biol. Chem. 279, 32181-32190 (2004).
12. Saito, S. et al. Ligand-independent trans-activation of the platelet-derived growth factor receptor by reactive oxygen species requires protein kinase C-δ and c-Src. J. Biol. Chem. 277, 44695-44700 (2002).
13. Rosado, J. A. et al. Hydrogen peroxide generation induces pp60src activation in human platelets: evidence for the involvement of this pathway in store-mediated calcium entry. J. Biol. Chem. 279, 1665-1675 (2004).
14. Yang, K. S. et al. Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J. Biol. Chem. 277, 38029-38036 (2002).
15. Rhee, S. G., Bae, Y. S., Lee, S. R. & Kwon, J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000, PE1 (2000).
16. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809 (1993).
17. Ferns, G. A. et al. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253, 1129-1132 (1991).
18. Persson, C. et al. Site-selective regulation of platelet-derived growth factor beta receptor tyrosine phosphorylation by T-cell protein tyrosine phosphatase. Mol. Cell. Biol. 24, 2190-2201 (2004).
19. Lee, T. H. et al. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood 101, 5033-5038 (2003).
20. Kang, S. W. et al. Cytosolic peroxiredoxin attenuates the activation of Jnk and p38 but potentiates that of Erk in Hela cells stimulated with tumor necrosis factor-α. J. Biol. Chem. 279, 2535-2543 (2004).
21. Ohmi, K. et al. A novel aortic smooth muscle cell line obtained from p53 knock out mice expresses several differentiation characteristics. Biochem. Biophys. Res. Commun. 238, 154-158 (1997).
22. Schober, A. et al. Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice. Circulation 109, 380-385 (2004).
23. Woo, H. A. et al. Reversible oxidation of the active site cysteine of peroxiredoxins to cysteine sulfinic acid. Immunoblot detection with antibodies specific for the hyperoxidized cysteine-containing sequence. J. Biol. Chem. 278, 47361-47364 (2003).